{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:15:20Z","timestamp":1788444920298,"version":"build-2803163510"},"reference-count":24,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"unspecified","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,8,13]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diagnosing Parkinson\u2019s disease (PD) and related synucleinopathies in patients with early or atypical features remains challenging. Dopamine transporter single-photon emission CT (DaT SPECT) imaging and phosphorylated alpha-synuclein (p-Syn) skin biopsy are increasingly used, but their concordance and combined value in diagnostically uncertain, real-world patients are unknown. We evaluated whether these two biomarkers provide complementary rather than redundant diagnostic information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analysed patients evaluated at a tertiary movement disorders centre (January 2022\u2013March 2025) who presented with parkinsonism or tremor not meeting established criteria for PD, multiple system atrophy or dementia with Lewy bodies. 86 patients underwent p-Syn skin biopsy; 52 also underwent DaT SPECT. Using the treating neurologist\u2019s final clinical diagnosis as the reference standard, we calculated sensitivity, specificity, predictive values and concordance for each test and for combined (\u2018either-positive\u2019) testing and compared clinical features between concordant and discordant groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DaT SPECT and p-Syn biopsy showed similar sensitivity (79.0% and 79.0%) and specificity (74.0% and 81.0%) for synucleinopathy. Combined testing increased sensitivity to 95.6% but reduced specificity to 59.9%. Results were discordant in 30.8% of dual-tested patients; +DaT\/\u2212p-Syn patients more often reported hyposmia, whereas \u2212DaT\/+p\u2009Syn patients more often reported REM sleep behaviour disorder. Almost half of discordant cases ultimately met criteria for idiopathic PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DaT SPECT and p-Syn skin biopsy provide complementary, not redundant, diagnostic information. The high discordance, with eventual PD diagnosis in many cases, is consistent with the dual-origin (brain-first vs body-first) model of alpha-synuclein propagation. Both are best used as rule-in tests in early or diagnostically uncertain disease, where a negative result does not exclude a synucleinopathy; in advanced disease meeting full clinical criteria, they may have greater rule-out value. Combined testing improves early detection at a cost to specificity, with implications for trial enrolment and for interpreting biomarkers alongside symptom evolution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2026-001759","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:35:20Z","timestamp":1788442520000},"page":"e001759","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Complementary biomarkers or conflicting signals? DaT SPECT and synuclein skin biopsy in parkinsonian syndromes"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-7977","authenticated-orcid":false,"given":"A Enrique","family":"Martinez-Nunez","sequence":"first","affiliation":[{"name":"Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Walker-Pizarro","sequence":"additional","affiliation":[{"name":"Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Wagle Shukla","sequence":"additional","affiliation":[{"name":"Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Ramirez-Zamora","sequence":"additional","affiliation":[{"name":"Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA"},{"name":"Department of Neurology, University of Louisville, Louisville, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus R","family":"McFarland","sequence":"additional","affiliation":[{"name":"Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2026090306351501000_8.2.e001759.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22360"},{"key":"2026090306351501000_8.2.e001759.2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29317"},{"key":"2026090306351501000_8.2.e001759.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2022.10.065"},{"key":"2026090306351501000_8.2.e001759.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00030-2"},{"key":"2026090306351501000_8.2.e001759.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000641"},{"key":"2026090306351501000_8.2.e001759.6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13195-014-0067-0","article-title":"Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCANTM) in subjects with clinically uncertain parkinsonian syndromes","volume":"6","author":"Bajaj","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"2026090306351501000_8.2.e001759.7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.157370"},{"key":"2026090306351501000_8.2.e001759.8","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2021-0646"},{"key":"2026090306351501000_8.2.e001759.9","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987"},{"key":"2026090306351501000_8.2.e001759.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0792"},{"key":"2026090306351501000_8.2.e001759.11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"key":"2026090306351501000_8.2.e001759.12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"2026090306351501000_8.2.e001759.13","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29005"},{"key":"2026090306351501000_8.2.e001759.14","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000187889.17253.b1"},{"key":"2026090306351501000_8.2.e001759.15","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s00259-023-06171-x","article-title":"A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice","volume":"50","author":"Chahid","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026090306351501000_8.2.e001759.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04817-8"},{"key":"2026090306351501000_8.2.e001759.17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27431"},{"key":"2026090306351501000_8.2.e001759.18","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/4.3.341"},{"key":"2026090306351501000_8.2.e001759.19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.26476","article-title":"Peripheral Synucleinopathy in Early Parkinson\u2019s Disease: Submandibular Gland Needle Biopsy Findings","volume":"31","author":"Adler","year":"2016","journal-title":"Mov Disord"},{"key":"2026090306351501000_8.2.e001759.20","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209453","article-title":"Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism","volume":"102","author":"Hastings","year":"2024","journal-title":"Neurology"},{"key":"2026090306351501000_8.2.e001759.21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011935"},{"key":"2026090306351501000_8.2.e001759.22","doi-asserted-by":"crossref","first-page":"1510796","DOI":"10.3389\/fneur.2024.1510796","article-title":"Clinical utility of synuclein skin biopsy in the diagnosis and evaluation of synucleinopathies","volume":"15","author":"Isaacson","year":"2024","journal-title":"Front Neurol"},{"key":"2026090306351501000_8.2.e001759.23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JPD-202481","article-title":"The \u03b1-Synuclein Origin and Connectome Model (SOC Model) of Parkinson\u2019s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline","volume":"11","author":"Borghammer","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"2026090306351501000_8.2.e001759.24","doi-asserted-by":"crossref","DOI":"10.1002\/dad2.12189","article-title":"Clinico-pathological comparison of patients with autopsy-confirmed Alzheimer\u2019s disease, dementia with Lewy bodies, and mixed pathology","volume":"13","author":"Chatterjee","year":"2021","journal-title":"Alzheimers Dement (Amst)"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2026-001759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:35:22Z","timestamp":1788442522000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2026-001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,9,3]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjno-2026-001759"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2026-001759","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}